Detalhe da pesquisa
1.
Modeling the public health impact of malaria vaccines for developers and policymakers.
BMC Infect Dis
; 13: 295, 2013 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23815273
2.
Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in Africa.
Malar J
; 10: 224, 2011 Aug 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-21816029
3.
Development of a transmission-blocking malaria vaccine: progress, challenges, and the path forward.
Vaccine
; 32(43): 5531-9, 2014 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-25077422
4.
Vaccines today, vaccines tomorrow: a perspective.
Clin Exp Vaccine Res
; 2(1): 4-7, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23596584
5.
Malaria vaccine R&D in the Decade of Vaccines: breakthroughs, challenges and opportunities.
Vaccine
; 31 Suppl 2: B233-43, 2013 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-23598488
6.
Roadmap for the international collaborative epidemiologic monitoring of safety and effectiveness of new high priority vaccines.
Vaccine
; 31(35): 3623-7, 2013 Aug 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-23707171
7.
Aligning new interventions with developing country health systems: target product profiles, presentation, and clinical trial design.
Glob Public Health
; 7(9): 931-45, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22783872
8.
Producing a successful malaria vaccine: innovation in the lab and beyond.
Health Aff (Millwood)
; 30(6): 1065-72, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21653958
9.
Four year immunogenicity of the RTS,S/AS02(A) malaria vaccine in Mozambican children during a phase IIb trial.
Vaccine
; 29(35): 6059-67, 2011 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-21443960
10.
Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial.
Lancet Infect Dis
; 11(10): 741-9, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21782519
11.
Safety, immunogenicity and duration of protection of the RTS,S/AS02(D) malaria vaccine: one year follow-up of a randomized controlled phase I/IIb trial.
PLoS One
; 5(11): e13838, 2010 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-21079803
12.
Insights into long-lasting protection induced by RTS,S/AS02A malaria vaccine: further results from a phase IIb trial in Mozambican children.
PLoS One
; 4(4): e5165, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19365567